Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Would you be able to manage weekly injections, or would this be difficult for you
A new systematic review published in the journal eClinicalMedicine on Wednesday examined 48 studies that analyzed and predicted the outcomes of people who either had diabetes or were overweight or obese and took popular GLP-1 medications such as liraglutide (under brand names such as Victoza and Saxenda), semaglutide (under brand names such as Ozempic, Wegovy, Rybelsus) and tirzepatide (under brand names like Mounjaro and Zepbound)
STEP 4 is the important counterpoint: weight came back when treatment stopped, so this is a long-term treatment rather than a short course, and whether it is right for you is a decision for the prescribing doctor
For a real-life look at what taking a GLP-1 drug is really like, read our series, On My Weigh
US$ 25.69
US$ 27.59
US$ 22.69
US$ 29.04
US$ 29.70
US$ 27.69
US$ 25.82
